Back to News
Market Impact: 0.2
Alector Consensus Price Target Increased by 25.81% to $3.98
Source: Nasdaq
Analyst InsightsAnalyst EstimatesHealthcare & Biotech
The average one-year analyst price target for Alector was revised up 25.81% to $3.98 per share from $3.16, using the prior mean dated September 29, 2026. The figures are aggregate analyst targets compiled by Fintel and are not an investment recommendation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
ALEC0.35
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Investing.com’s stocks of the week
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data
- Best AI Stock Research Tools for Professional Investors